A simple strategy could make first-line antibiotics more effective against resistant bacteria
Researchers have identified a single, simple metric to inform medication regimen design that could bring an entire arsenal of first-line antibiotics back into the fight against drug-resistant pathogens.
A computer simulation created by Hannah Meredith, a biomedical engineering graduate fellow at Duke University, revealed that a regimen based on a pathogen’s recovery time could eliminate an otherwise resistant strain of bacteria. In theory, a database of recovery times for bacterial and antibiotic combinations could allow first-line antibiotics to clear many resistant infections.
Meredith has already begun lab work to create such a database, and early tests are confirming her model’s predictions.
The study appears in PLOS Computational Biology on April 23, 2015.
“Bacteria are forming resistance to antibiotics faster than we can make new ones, so there is a real need to use the antibiotics that are already on the market more efficiently,” said Meredith. “We hope this research will help hospitals improve patient outcomes while also making our antibiotics last as long as possible.”
The computer simulation models the relationship between bacteria, antibiotics and a method of resistance called beta-lactamase—an enzyme that degrades beta-lactam antibiotics, one of the largest and most-used classes of antibiotics. Many beta-lactam antibiotics are currently disregarded out of concern for the infection being completely resistant to that type of antibiotic—even if the antibiotic appeared to be effective in the lab. The new model, however, reveals that the infection might be temporarily sensitive to the antibiotic before the beta-lactamase degrades the drug and allows the infection to recover.
“You can think of this as a race between the cells and the antibiotics,” said Lingchong You, the Paul Ruffin Scarborough Associate Professor of Biomedical Engineering at Duke and Meredith’s advisor. “Before their beta-lactamase degrades the antibiotics, the cells are still sensitive and can be killed. But the antibiotics degrade faster than the cell population declines, allowing some cells to survive and repopulate.”
When clinicians realize an infection is resistant, they often skip straight to some of the strongest antibiotics available. But the study indicates that if they instead changed the dosing frequency of first-line antibiotics such that each dose is delivered while the bacteria are weakened during their recovery period, some infections could be cleared without skipping to the last resort.
Doctors also need to be careful, however, not to wreck native populations of bacteria vital to human health. A database detailing the responses of different strains to different antibiotics could allow Meredith’s computer model to determine the most efficient regimen to keep total exposure to a minimum. It could also indicate if multiple doses would not work, letting clinicians know when it is time to call in the heavy artillery.
Read more: Finding New Life for First-Line Antibiotics
The Latest on: Antibiotics
via Google News
The Latest on: Antibiotics
- Scientists spy on superbugs to see how they outsmart our antibiotics on May 23, 2019 at 9:00 pm
Scientists have discovered yet another way that single-celled organisms have outsmarted us. The tiny bacteria that live inside our guts have an ingenious way of withstanding the onslaught of ... […]
- Health Beat: Making antibiotics work better on May 23, 2019 at 6:20 pm
BOULDER, Colo. - Each year, 23,000 Americans die from an antibiotic-resistant infection. "The days when you can give a patient an antibiotic and you were pretty darn sure it was going to work are ... […]
- How Bacteria Become Drug-Resistant While Exposed to Antibiotics on May 23, 2019 at 11:37 am
Escherichia coli is capable of synthesizing drug-resistant proteins even in the presence of antibiotics designed to cripple cell growth. That’s the finding by a group of French researchers reporting ... […]
- Wendy’s Burgers Made With “Old-Fashioned” Antibiotics Policy on May 23, 2019 at 8:00 am
It’s time for the fast-food giant to do its part in fighting one of today’s greatest global health threats. Matthew Staver/Bloomberg via Getty Images Next week, millions of Americans will have ... […]
- Why Do Germs Become Resistant to Antibiotics? An MSK Program Is Focused on Avoiding this Problem on May 22, 2019 at 1:17 pm
In this Q & A, infectious disease expert Susan Seo discusses MSK’s Antibiotic Management Program. It ensures that antibiotics and other antimicrobial drugs are used responsibly. The rapid emergence of ... […]
- Study finds lower ER triage scores associated with delayed antibiotics delivery for sepsis patients on May 22, 2019 at 7:53 am
Providing early, appropriate antibiotic treatment for patients with sepsis—a serious complication of infection that can lead to organ failure and death—is crucial for their survival. ... […]
- Scientists searching for ways to make antibiotics work better on May 21, 2019 at 3:15 am
At least 2 million Americans will develop an antibiotic-resistant infection this year. Each year, 23,000 Americans die from an antibiotic-resistant infection. These resistant infections are on the ... […]
- Aptasensor for multiplex detection of antibiotics based on FRET strategy combined with aptamer/graphene oxide complex on May 21, 2019 at 2:12 am
The development of a multiplexed sensing platform is necessary for highly selective, sensitive, and rapid screening of specific antibiotics. In this study, we designed a novel multiplex aptasensor for ... […]
- Global Antibiotics Partnering Terms and Agreements Directory 2014 to 2019 - Deal Trends, Players and Financials Analysis - ResearchAndMarkets.com on May 20, 2019 at 4:35 am
The "Global Antibiotics Partnering Terms and Agreements 2014 to 2019: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The Global Antibiotics Partnering ... […]
- Antibiotics 2019 Market By: Industry Size,Growth,Trends,Analysis,Opportunities, and Forecasts to 2023 on May 20, 2019 at 2:08 am
The analysts forecast the global antibiotics market to grow at a CAGR of 2.16% during the period 2017-2021. An antibiotic is a chemical compound that kills or slows down the growth of any ... […]
via Bing News